IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 191 filers reported holding IMMUNOVANT INC in Q3 2023. The put-call ratio across all filers is 2.28 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $107,413,492 | +4.4% | 2,797,955 | -48.4% | 4.15% | -12.9% |
| Q2 2023 | $102,842,630 | -10.8% | 5,421,330 | -27.1% | 4.76% | +0.5% |
| Q1 2023 | $115,281,441 | -33.1% | 7,432,717 | -23.5% | 4.74% | -34.6% |
| Q4 2022 | $172,352,500 | +213.3% | 9,710,000 | -1.5% | 7.24% | +187.1% |
| Q3 2022 | $55,020,000 | +49.2% | 9,860,246 | +4.3% | 2.52% | +4.0% |
| Q2 2022 | $36,875,000 | -7.4% | 9,455,000 | +30.9% | 2.42% | -5.1% |
| Q1 2022 | $39,808,000 | -2.2% | 7,224,613 | +51.3% | 2.55% | -11.1% |
| Q4 2021 | $40,683,000 | – | 4,775,000 | – | 2.87% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
| Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
| Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
| Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
| Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
| BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
| Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |